Transmission of risk-group specific HIV-1 strains among Dutch drug users for more than 20 years and their replacement by nonspecific strains after switching to low-harm drug practices

Journal of Acquired Immune Deficiency Syndromes

Volumn 62, Issue 2, 2013, Pages 234-238

  Lukashov, Vladimir V ^a   Jurriaans, Suzanne ^b   Bakker, Margreet ^a   Berkhout, Ben ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

drug users; epidemiological networks; HIV 1; men having sex with men; molecular epidemiology; the Netherlands

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DRUG ABUSE; EPIDEMIC; FEMALE; GENETIC MARKER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; NETHERLANDS; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; STRUCTURAL GENE; UNINDEXED SEQUENCE; VIRUS STRAIN;

BIOLOGICAL MARKERS; CLUSTER ANALYSIS; COHORT STUDIES; FEMALE; GENES, POL; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; NETHERLANDS; PHYLOGEOGRAPHY; RISK REDUCTION BEHAVIOR; SEQUENCE ANALYSIS, DNA; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS;

EID: 84872843593     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318279734d     Document Type: Article

References (42)

1. Haastrecht van HJA, van den Hoek JAR, et al. Did the introduction of HIV among homosexual men precede the introduction of HIV among injecting drug users in the Netherlands? AIDS. 1992;6:131-132.
2. van den Hoek JA, van Haastrecht HJ, Coutinho RA. Homosexual prostitution among male drug users and its risk for HIV infection. Genitourin Med. 1991;67:303-306.
3. Kuiken C, Goudsmit J. Silent mutation pattern in V3 sequences distinguishes virus according to risk group in Europe. AIDS Res Hum Retroviruses. 1994; 10:319-320. (Pubitemid 24116790)
4. Kuiken CL, Cornelissen MTE, Zorgdrager F, et al. Consistent risk groupassociated differences in human immunodeficiency virus type 1 vpr, vpu and V3 sequences despite independent evolution. J Gen Virol. 1996;77: 783-792. (Pubitemid 26121811)
5. Engelstad M. Genetic diversity of env V3 loop sequences in HIV type 1-infected homosexuals, heterosexuals, intravenous drug users, and hemophilia patients in Norway: high prevalence of subtype B and detection of subtype C. AIDS Res Hum Retroviruses. 1996;12: 1733-1738. (Pubitemid 26424054)
6. Rojas JM, Dopazo J, Najera I, et al. Molecular epidemiology of HIV-1 in Madrid. Virus Res. 1994;31:331-342. (Pubitemid 24073961)
7. Lukashov VV, Kuiken CL, Vlahov D, et al. Evidence for HIV type 1 strains of U.S. intravenous drug users as founders of AIDS epidemic among intravenous drug users in Northern Europe. AIDS Res Hum Retroviruses. 1996;12:1179-1183. (Pubitemid 26317421)
8. Lukashov VV, Goudsmit J. Recent evolutionary history of human immunodeficiency virus type 1 subtype B: reconstruction of epidemic onset based on sequence distances to the common ancestor. J Mol Evol. 2002; 54:680-691. (Pubitemid 34297950)
9. Op de Coul EL, Prins M, Cornelissen M, et al. Using phylogenetic analysis to trace HIV-1 migration among western European injecting drug users seroconverting from 1984 to 1997. AIDS. 2001;15:257-266. (Pubitemid 32142303)
10. Lukashov VV, Op de Coul EL, Coutinho RA, et al. HIV-1 strains specific for Dutch injecting drug users in heterosexually infected individuals in The Netherlands. AIDS. 1998;12:635-641. (Pubitemid 28162103)
11. Bezemer D, Jurriaans S, Prins M, et al. Declining trend in transmission of drug-resistant HIV-1 in Amsterdam. AIDS. 2004;18:1571-1577. (Pubitemid 39037481)
12. Korber B,Myers G. Signature pattern analysis: a method for assessing viral sequence relatedness. AIDS Res Hum Retroviruses. 1992;8:1549-1560.
13. Albert J, Wahlberg J, Leitner T, et al. Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes. J Virol. 1994;68:5918-5924. (Pubitemid 24258609)
14. Leitner T, Escanilla D, Franzen C, et al. Accurate reconstruction of a known HIV-1 transmission history by phylogenetic tree analysis. Proc Natl Acad Sci U S A. 1996;93:10864-10869. (Pubitemid 26333082)
15. Cornelissen M, Mulder-Kampinga G, Veenstra J, et al. Syncitium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population. J Virol. 1995;69:1810-1818.
16. Leitner T. Guidelines for HIV in court cases. Nature. 2011;473:284.
17. van der Kuyl AC, Jurriaans S, Back NK, et al. Unusual cluster of HIV type 1 dual infections in Groningen, The Netherlands. AIDS Res Hum Retroviruses. 2011;27:429-433.
18. Kouyos RD, von Wyl V, Yerly S, et al. Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland. J Infect Dis. 2010;201:1488-1497.
19. Oster AM, Wiegand RE, Sionean C, et al. Understanding disparities in HIV infection between black and white MSM in the United States. AIDS. 2011;25:1103-1112.
20. Kalish ML, Luo C-C, Weniger BG, et al. Early HIV type 1 strains in Thailand were not responsible for the current epidemic. AIDS Res Hum Retroviruses. 1994;10:1573-1575. (Pubitemid 24382211)
21. Ou C-Y, Takebe Y, Weniger BG, et al. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet. 1993;341:1171-1174. (Pubitemid 23137112)
22. Abebe A, Lukashov VV, Pollakis G, et al. Timing of the HIV-1 subtype C epidemic in Ethiopia based on early virus strains and subsequent virus diversification. AIDS. 2001;15:1555-1561. (Pubitemid 32744603)
23. Abebe A, Lukashov VV, Rinke De Wit TF, et al. Timing of the introduction into Ethiopia of subcluster C′ of HIV type 1 subtype C. AIDS Res Hum Retroviruses. 2001;17:657-661. (Pubitemid 32686092)
24. Bobkov AF, Lukashov VV, Goudsmit J, et al. Silent mutation in the V3 region characteristic of HIV type 1 env subtype B strains from injecting drug users in the former Soviet Union. AIDS Res Hum Retroviruses. 2000;16:291-294. (Pubitemid 30111965)
25. Lazouskaya NV, Eremin VF, Adema KW, et al. The HIV type 1 epidemic in Belarus: predominance of Eastern European subtype A strains and circulation of subtype B viruses. AIDS Res Hum Retroviruses. 2005;21: 830-833. (Pubitemid 41434190)
26. Lukashov VV, Cornelissen MTE, Goudsmit J, et al. Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Byelorussia and Lithuania. AIDS. 1995;9:435-439.
27. Lukashov VV, Kuiken CL, Boer K, et al. HIV type 1 subtypes in The Netherlands circulating among women originating from AIDS endemic regions. AIDS Res Hum Retroviruses. 1996;12:951-953. (Pubitemid 26230792)
28. Lukashov VV, Huismans R, Rakhmanova AG, et al. Circulation of subtype A and gagA/envB recombinant HIV type 1 strains among injecting drug users in St. Petersburg, Russia, correlates with geographical origin of infections. AIDS Res Hum Retroviruses. 1999;15:1577-1583.
29. Nabatov AA, Kravchenko ON, Lyulchuk MG, et al. Simultaneous introduction of HIV type 1 subtype A and B viruses into injecting drug users in southern Ukraine at the beginning of the epidemic in the former Soviet Union. AIDS Res Hum Retroviruses. 2002;18:891-895. (Pubitemid 35034672)
30. Op de Coul EL, Coutinho RA, van der Schoot A, et al. The impact of immigration on env HIV-1 subtype distribution among heterosexuals in the Netherlands: influx of subtype B and non-B strains. AIDS. 2001;15: 2277-2286. (Pubitemid 34059835)
31. Rumyantseva OA, Olkhovskiy IA, Malysheva MA, et al. Epidemiological networks and drug resistance of HIV type 1 in Krasnoyarsk region, Russia. AIDS Res Hum Retroviruses. 2009;25:931-936.
32. Nabatov AA, Masharsky AE, Verevochkin SV, et al. The rate of epidemiological and virological changes during the transition from nascent to concentrated HIV epidemic stage in the former Soviet Union countries. AIDS Res Hum Retroviruses. 2007;23:183-192. (Pubitemid 46418331)
33. Bezemer D, van Sighem A, Lukashov VV, et al. Transmission networks of HIV-1 among men having sex with men in the Netherlands. AIDS. 2010;24:271-282.
34. Graw F, Leitner T, Ribeiro RM. Agent-based and phylogenetic analyses reveal how HIV-1 moves between risk groups: injecting drug users sustain the heterosexual epidemic in Latvia. Epidemics. 2012;4:104-116.
35. Smith DM, May SJ, Tweeten S, et al. A public health model for the molecular surveillance of HIV transmission in San Diego, California. AIDS. 2009;23:225-232.
36. Van Den Berg C, Smit C, van Brussel G, et al. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Addiction. 2007;102:1454-1462. (Pubitemid 47246988)
37. Lambers FA, Stolte IG, van den Berg CH, et al. Harm reduction intensity- its role in HAART adherence amongst drug users in Amsterdam. Int J Drug Policy. 2011;22:210-218.
38. Smit C, Lindenburg K, Geskus RB, et al. Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour. Addiction. 2006;101:433-440. (Pubitemid 43344826)
39. van den Berg N, Grady BPX, Schim van der Loeff MF, et al. Low risk of HIV and STI among drug users in Amsterdam [Abstract A-452-0147-08988]. Paper presented at: International AIDS Conference; July 22-27, 2012; Washington, DC.
40. Jansen IA, Geskus RB, Davidovich U, et al. Ongoing HIV-1 transmission among men who have sex with men in Amsterdam: a 25-year prospective cohort study. AIDS. 2011;25:493-501.
41. Heijman T, Geskus RB, Davidovich U, et al. Less decrease in risk behaviour from pre-HIV to post-HIV seroconversion among MSM in the combination antiretroviral therapy era compared with the pre-combination antiretroviral therapy era. AIDS. 2011;26:489-495.
42. Lindenburg CE, Krol A, Smit C, et al. Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users inAmsterdam: a 19-year prospective cohort study. AIDS. 2006;20:1771-1775. (Pubitemid 44299369)